Petros Pharmaceuticals Inc (NASDAQ:PTPI) currently has a daily average trading volume of 35.63M but it saw 3845734 shares traded in last market. With a market cap of 2.55M USD, the company’s current market price of $0.05 came falling about -8.11 while comparing to the previous closing price of $0.05. In past 52 weeks, the stock remained buoying in the range of price level as high as $0.94 and as low as $0.05. In the recent trading on the day, stock has struck highest price mark of $0.0456 while lowest mark touched by it was $0.0508.
Taking a look at 20-day trading activity of Petros Pharmaceuticals Inc (PTPI) gives us an average price of $0.0747, while its current price level is -94.94% below from 52-week high level whereas it is 4.62% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.1326 while that of 200 days or SMA-200 reads an average of $0.2974. A closer look into the stock’s movement over the week reveals that its volatility is standing at 19.11% during that period while stretching the period over a month that increases to 21.92%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 36.08 which implies that the stock is in neutral territory.
Over the week, PTPI’s stock price is moving -30.51% down while it is -48.20% when we observe its performance for the past one month. Year-to-date it is -87.92% down and over the past year, the stock is showing a downside performance of -94.77%.
The company is expected to be releasing its next quarterly report on 2024-Nov-12, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Petros Pharmaceuticals Inc’s total number of outstanding shares is 53.52M with 6.01% of that held by the insiders while 4.86% of its common stock has been owned by the institutions. Stock’s beta reads 2.13. Stock has a price to sale or P/S ratio amounts to 0.50.
